Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cyran OW"'
Autor:
Gupta, S, Dovey, OM, Domingues, AF, Cyran, OW, Cash, CM, Giotopoulos, G, Rak, J, Cooper, J, Gozdecka, M, Asby, RJ, Al-Jabery, N, Hernandez, V, Prabakaran, S, Huntly, BJ, Vassiliou, GS, Pina, C
Competing Interest Statement: VH-H is co-Founder and CSO of Axovia Therapeutics. SP is the CEO of NonExomics, Inc. Axovia and NonExomics did not provide funding to this study, and did not influence study design, execution, data analysis or interpreta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______900::f0ab918d94e6629d17100ad8e331b4bd
https://bura.brunel.ac.uk/handle/2438/24351
https://bura.brunel.ac.uk/handle/2438/24351
Autor:
Gupta S; Department of Genetics, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Dovey OM; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK., Domingues AF; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Cyran OW; Department of Haematology, University of Cambridge, Cambridge, UK., Cash CM; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK., Giotopoulos G; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Rak J; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Cooper J; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Gozdecka M; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Dijkhuis L; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK., Asby RJ; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Al-Jabery N; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK., Hernandez-Hernandez V; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK.; Centre for Genome Engineering and Maintenance, Brunel University London, Uxbridge, UB8 3PH, UK., Prabakaran S; NonExomics Inc., Boston, MA, USA., Huntly BJ; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Vassiliou GS; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Pina C; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK.; Centre for Genome Engineering and Maintenance, Brunel University London, Uxbridge, UB8 3PH, UK.
Publikováno v:
Science advances [Sci Adv] 2022 Aug 05; Vol. 8 (31), pp. eabn4886. Date of Electronic Publication: 2022 Aug 03.
Autor:
Fletcher CE; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK. claire.fletcher07@imperial.ac.uk., Deng L; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Orafidiya F; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Yuan W; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Lorentzen MPGS; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Cyran OW; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Varela-Carver A; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Constantin TA; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Leach DA; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Dobbs FM; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK.; Broken String Biosciences, Unit AB303, Level 3, BioData Innovation Centre, Wellcome Genome Campus, Hinxton, Cambridge, UK., Figueiredo I; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Gurel B; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Parkes E; Institute for Radiation Oncology, Department of Oncology, University of Oxford, London, UK., Bogdan D; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Pereira RR; Translational Oncogenomics, Manchester Cancer Research Centre and Cancer Research UK Manchester Institute, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK., Zhao SG; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Neeb A; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Issa F; Transplantation Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Hester J; Transplantation Research and Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Kudo H; Section of Pathology, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Liu Y; Veracyte, Inc., San Diego, CA, USA., Philippou Y; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK., Bristow R; Translational Oncogenomics, Manchester Cancer Research Centre and Cancer Research UK Manchester Institute, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Christie NHS Foundation Trust, Manchester, UK., Knudsen K; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.; American Cancer Society and American Cancer Society Cancer Action Network, Washington DC, USA., Bryant RJ; Institute for Radiation Oncology, Department of Oncology, University of Oxford, London, UK., Feng FY; Departments of Urology and Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Reed SH; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK., Mills IG; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.; Patrick G Johnston Centre for Cancer Research, Queen's University of Belfast, Belfast, UK.; Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., de Bono J; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Bevan CL; Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, London, UK.
Publikováno v:
Molecular cancer [Mol Cancer] 2022 Mar 22; Vol. 21 (1), pp. 82. Date of Electronic Publication: 2022 Mar 22.